These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37486753)
41. Effect of collagen I and aortic carboxypeptidase-like protein on 3T3-L1 adipocyte differentiation. Gusinjac A; Gagnon A; Sorisky A Metabolism; 2011 Jun; 60(6):782-8. PubMed ID: 20817214 [TBL] [Abstract][Full Text] [Related]
42. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts. Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
45. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. Tokuda H; Kozawa O; Uematsu T J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202 [TBL] [Abstract][Full Text] [Related]
46. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. Kuno M; Takai S; Matsushima-Nishiwaki R; Minamitani C; Mizutani J; Otsuka T; Harada A; Adachi S; Kozawa O; Tokuda H Biochem Pharmacol; 2009 Jan; 77(2):196-203. PubMed ID: 18996357 [TBL] [Abstract][Full Text] [Related]
47. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts. Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907 [TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. Karsdal MA; Larsen L; Engsig MT; Lou H; Ferreras M; Lochter A; Delaissé JM; Foged NT J Biol Chem; 2002 Nov; 277(46):44061-7. PubMed ID: 12226090 [TBL] [Abstract][Full Text] [Related]
49. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction. Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547 [TBL] [Abstract][Full Text] [Related]
50. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts. Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250 [TBL] [Abstract][Full Text] [Related]
51. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase. Kim W; Tokuda H; Kawabata T; Fujita K; Sakai G; Nakashima D; Tachi J; Kuroyanagi G; Matsushima-Nishiwaki R; Tanabe K; Otsuka T; Iida H; Kozawa O Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106327. PubMed ID: 30946899 [TBL] [Abstract][Full Text] [Related]
52. Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. Lin Y; Shen X; Ke Y; Lan C; Chen X; Liang B; Zhang Y; Yan S FASEB J; 2022 Mar; 36(3):e22147. PubMed ID: 35104016 [TBL] [Abstract][Full Text] [Related]
53. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042 [TBL] [Abstract][Full Text] [Related]
54. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts. Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094 [TBL] [Abstract][Full Text] [Related]